Cargando…
CIHR Canadian HIV Trials Network Co-Infection and Concurrent Diseases Core: Updated Canadian guidelines for the treatment of hepatitis C infection in HIV-hepatitis C coinfected adults
BACKGROUND: Hepatitis C virus (HCV) coinfection occurs in 20% to 30% of Canadians living with HIV and is responsible for a heavy burden of morbidity and mortality. Management of HIV-HCV coinfection is more complex due to the accelerated progression of liver disease, the timing and nature of antiretr...
Autores principales: | Hull, Mark, Shafran, Stephen, Tseng, Alice, Giguère, Pierre, Klein, Marina B, Cooper, Curtis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pulsus Group Inc
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277159/ https://www.ncbi.nlm.nih.gov/pubmed/25587293 |
Ejemplares similares
-
CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment
por: Hull, Mark, et al.
Publicado: (2016) -
Favourable IFNL3 Genotypes Are Associated with Spontaneous Clearance and Are Differentially Distributed in Aboriginals in Canadian HIV-Hepatitis C Co-Infected Individuals
por: Moqueet, Nasheed, et al.
Publicado: (2015) -
Trends in cause-specific mortality in HIV–hepatitis C coinfection following hepatitis C treatment scale-up
por: Kronfli, Nadine, et al.
Publicado: (2019) -
CIHR canadian HIV trials network HIV workshop: ethical research through community participation and strengthening scientific validity
por: Mbuagbaw, Lawrence, et al.
Publicado: (2014) -
Output from the CIHR Canadian HIV Trials Network international postdoctoral fellowship for capacity building in HIV clinical trials
por: Mbuagbaw, Lawrence, et al.
Publicado: (2018)